This inventor holds 3 USPTO granted patents. Top assignee: Sosei R&d Ltd.. Active years: 2007-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007-2011
Title: David A V Morton: Innovator in Respiratory Disease Treatment
Introduction
David A V Morton is a notable inventor based in Bath, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of respiratory diseases. With a total of 3 patents to his name, Morton's work focuses on innovative solutions that enhance patient care and treatment efficacy.
Latest Patents
Among his latest patents, Morton has developed a pharmaceutical composition for pulmonary delivery that comprises glycopyrrolate in a controlled release formulation. This formulation is designed to exert its pharmacological effect over a period greater than 12 hours upon administration. This innovation aims to improve the management of respiratory diseases by providing sustained relief to patients.
Career Highlights
Morton is currently associated with Sosei R&D Ltd., where he continues to advance his research and development efforts. His work is characterized by a commitment to improving therapeutic options for individuals suffering from respiratory conditions.
Collaborations
Throughout his career, Morton has collaborated with esteemed colleagues, including Robin Mark Bannister and Andrew John McGlashan Richards. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
David A V Morton stands out as a dedicated inventor in the pharmaceutical industry, particularly in the realm of respiratory disease treatment. His innovative patents and collaborative efforts contribute significantly to advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile